Skip to main content
OpenTrials
Completed

NCT Number: NCT04298151

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Geriatric Performance

Age range

60 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Doaa Abdou

Giza, 12573, Egypt

About this study

This study will be conducted to determine the clinical performance of the Zirconia reinforced glass ionomer restorations ( Zirconomer improved) under stress bearing posterior area (class I or claa II cavities) in geriatric population in comparison to Conventional viscous glass ionomer restorations (Ketac molar quick Aplicap) using the modified United States Public Health Service (USPHS) criteria

P: Geriatric Patients with posterior Caries lesions I: Zirconia reinforced GI (Zirconomer Improved) C: Conventional viscous GI, (Ketac Molar quick Aplicap) O: The Clinical performance of the Glass Ionomer restorations Using USPHS Criteria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age range 60-80 years
  • Geriatric patients with Class I or II Posterior carious lesions.
  • Males or Females.
  • Pulp asymptomatic vital carious posterior teeth.
  • Co-operative patients approving to participate in the trial.

Exclusion criteria

  • Age range less than 60 years.
  • Disabilities.
  • Deep extensive carious cavities that may lead to fracture of the tooth or pulpal affection.
  • Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
  • Heavy smoking.
  • Lack of compliance.

Treatment and study plan

Zirconomer Improved

Drug

glass ionomer restoration reinforced with nano-zirconia particles to improve strength and esthetics

Other names: zirconia reinforced GI

Ketac Molar quick Aplicap

Drug

highly viscous glass ionomer with improved mechanical properties than the conventional GI

Other names: KMQ aplicap

Primary outcomes

  1. Clinical performance

    Time frame: 1 year

    clinical performance of the Glass Ionomer restorations using modified USPHS criteria

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical Evaluation of Zirconia Reinforced Versus Conventional Viscous Glass Ionomer in Posterior Restorations of Geriatric Patients: Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Mar 6, 2020
Registry last updated
Feb 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.